A Phase 1, Randomized, Placebo-controlled, Single- and Multiple- dose, Double-blind Study to Evaluate the Pharmacokinetics and Safety of Rimegepant (BHV-3000) Orally Disintegrating Tablets 75mg in Healthy Adult Chinese Subjects
| Title | A Phase 1, Randomized, Placebo-controlled, Single- and Multiple- dose, Double-blind Study to Evaluate the Pharmacokinetics and Safety of Rimegepant (BHV-3000) Orally Disintegrating Tablets 75mg in Healthy Adult Chinese Subjects |
|---|---|
| Description | This was a Phase 1, randomized, placebo-controlled, single- and multiple-dose, double-blind study to evaluate the PK and safety of rimegepant ODT 75mg in healthy Chinese subjects. To evaluate the pharmacokinetics (PK) (single and multiple dose daily) profile of rimegepant ODT 75mg in Chinese subjects. To confirm the safety profile of rimegepant ODT 75mg in Chinese subjects, up to 6 doses. |
| Organism | Homo sapiens |
| Data Type | Metabolome Data by Mass Spectrometry (MS) |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA011832 |
| Release Date | 2024-09-14 |
| Submitter | Jiaqiu Xu (xujiaqiu2017@126.com) |
| Organization | Hangzhou Tigermed Consulting Co.,Ltd. |
| Submission Date | 2022-09-14 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX001838-01 | BHV-3000-118_PK_COVANCE_18Jun2021 | 448 | Metabolome Data by Mass Spectrometry (MS) | 90.5 KB | xls | 0 | Controlled |